Philadelphia Investment Partners »

Axsome Therapeutics shares owned by Philadelphia Investment Partners

Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Philadelphia Investment Partners from 13F filings

Historical chart of Philadelphia Investment Partners investment in Axsome Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Axsome Therapeutics held by Philadelphia Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axsome Therapeutics by Philadelphia Investment Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $433k 2.6k 169.03

More positions owned by Philadelphia Investment Partners

Vaneck Vectors Tr Fallen Angel Hg Etf (ANGL)
Palantir Technologies (PLTR)
Vaneck Vectors Tr Morningstar Wide Etf (MOAT)
Ishares Tr 3 7 Yr Treas Etf (IEI)
Ishares Tr Blackrock Etf (ICSH)
Spdr Series Trust Prtflo S&p500 Gw Etf (SPYG)
Ea Series Trust Freedom 100 Em (FRDM)
Dbx Tr Xtrak Msci Eafe Etf (DBEF)
NVIDIA Corporation (NVDA)
J P Morgan Exchange Traded F Global Bd Etf (JPIB)
Apple (AAPL)
Vanguard Admiral Fds Inc Smllcp 600 Etf (VIOO)
Blackstone Group Inc Com Cl A (BX)
JPMorgan Chase & Co. (JPM)
Select Sector Spdr Tr Energy Etf (XLE)

View all positions for Philadelphia Investment Partners

Top funds holding Axsome Therapeutics

Vanguard Group
BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
FMR
Invesco
Geode Capital Management
Wellington Management Company
Deep Track Capital
State Street Corporation
Assenagon Asset Management
Nomura Asset Management International
Adage Capital Partners GP
Alethea Capital Management
D. E. Shaw & Co

View all funds holding Axsome Therapeutics